FONR (FONR)

FONAR Corporation, a medical imaging company, has finalized a going-private merger with FONAR Acquisition Sub, Inc., effective June 3, 2026. DLA Piper advised FONAR Corporation on this transaction. Access to further details requires a standard 1-year membership.

The 2026 Annual General Meeting for FONAR (FONR) was held virtually on May 28, 2026. Stockholders approved a merger proposal where FONAR Acquisition Sub, Inc. will merge with FONAR, making it a wholly owned subsidiary. A proposed adjournment for additional proxy solicitation was not needed as the merger was approved.

Dimensional Fund Advisors LP has reported that it no longer holds any shares of FONAR Corp (FONR) common stock. As of June 30, 2026, the firm beneficially owns 0 shares, representing 0.0% of the class. Dimensional disclaims beneficial ownership of these securities, stating that they are owned by underlying funds and accounts for which Dimensional acts as an adviser or sub-adviser.

Fonar Corp (NASDAQ:FONR) specializes in niche MRI technology, particularly upright MRI systems, catering to diagnostic imaging centers. The company's business model combines equipment sales with recurring revenue from service contracts and sometimes joint ventures with imaging centers. Their unique upright MRI systems aim to improve patient experience and diagnostic capabilities, especially in load-bearing scenarios.

Fonar Corp (FONR) is a medical-imaging company focusing on MRI systems and imaging services, trading on Nasdaq. Its core product is the Upright MRI platform, designed for weight-bearing patient imaging. The company's business model provides layered revenue from equipment sales and utilization through its imaging centers.